Related Experiment Video
Updated: Aug 9, 2026
16:27
Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 3, 2010
[Sphingolipid signaling: a potential pathway for TNF-alpha induced preconditioning]
1Hatter Institute for Cardiology Research, MRC Inter-University Cape Heart Group, Chris Barnard Building, University of Cape Town Medical School, Cape Town 7925, Afrique du Sud. sandrine@capeheart.uct.ac.za
Annales De Cardiologie Et D'Angeiologie
|February 3, 2004
Summary
Cytokines, like tumor necrosis factor-alpha (TNF alpha), may enhance heart protection during ischemia. Exploring cytokine-activated sphingolipid pathways could reveal key cardioprotective mechanisms.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Immunology
Context:
- Cardiac ischemia and reperfusion injury are significant clinical challenges.
- Ischemic preconditioning is a known phenomenon that protects the heart against lethal ischemia.
- The precise molecular mechanisms underlying ischemic preconditioning remain incompletely understood.
Purpose:
- To explore the potential role of cytokine activation in mediating cardioprotective effects.
- To investigate the involvement of tumor necrosis factor-alpha (TNF alpha) in the preconditioned phenotype.
- To examine how cytokine-activated sphingolipid signaling pathways contribute to understanding preconditioning.
Summary:
- Cytokine activation, particularly TNF alpha, is increasingly implicated in the cardioprotective effects observed during ischemic preconditioning.
- Ischemic preconditioning involves a transient ischemic trigger that confers resistance to subsequent lethal ischemia.
- Sphingolipid signaling pathways activated by cytokines offer a promising avenue for elucidating the molecular basis of this protective phenomenon.
Impact:
- This research may uncover novel therapeutic targets for preventing heart damage during ischemic events.
- Understanding cytokine-mediated pathways could lead to new strategies for enhancing cardiac resilience.
- The findings could advance the field of cardiovascular protection by clarifying the role of innate cytoprotective programs.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...